Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
09/2010
09/07/2010CA2457401C Transdermal therapeutic system containing fentanyl or related substances
09/07/2010CA2457245C Transdermal therapeutic system (tts) containing the active substance fentanyl
09/07/2010CA2450771C Reservoir device for intraocular drug delivery
09/07/2010CA2431188C Pharmaceutical compositions enhancing the immunogenicity of poorly immunogenic antigens
09/07/2010CA2429650C Oral pharmaceutical compositions containing cyclodextrins as taste masking agent
09/07/2010CA2351273C Solution of n-[o-(p-pivaloyloxybenzenesulfonylamino) benzoyl] glycine monosodium salt tetra-hydrate and drug product thereof
09/07/2010CA2334615C Production process for polymeric micelle charged therein with drug and polymeric micelle composition
09/02/2010WO2010099552A2 Devices, systems and methods for magnetic-assisted therapeutic agent delivery
09/02/2010WO2010099542A2 Formulations of atp and analogas of atp
09/02/2010WO2010099523A1 Method of treating reactive airway disease
09/02/2010WO2010099510A2 Amino acid-based compounds, their methods of use, and methods of screening
09/02/2010WO2010099368A1 Ocular implants comprising kinase inhibitors
09/02/2010WO2010099292A2 Biodegradable drug or other active delivery system
09/02/2010WO2010099087A1 Effervescent nutritional and/or dietary supplement composition
09/02/2010WO2010098627A2 Pharmaceutical preparation
09/02/2010WO2010098625A2 Pharmaceutical preparation
09/02/2010WO2010098482A1 Stable capsule preparation and method for producing same
09/02/2010WO2010098433A1 Coenzyme q10-containing composition for oral ingestion
09/02/2010WO2010098417A1 Magnesium oxide fine granules
09/02/2010WO2010098265A1 Polymeric micelle containing proteasome inhibitor
09/02/2010WO2010098261A1 Risperidone-containing transdermal preparation and adhesive patch using same
09/02/2010WO2010098230A1 Transdermal preparation
09/02/2010WO2010097814A2 A controlled release micro-capsule for osteogenic action
09/02/2010WO2010097773A1 Topical or transdermal delivery kit
09/02/2010WO2010097699A1 Phospholipid and protein tablets
09/02/2010WO2010097643A1 Formulation based on micronized zeolite, green tea extract, and genistein as a therapeutic agent for reduction of body weight and cellulite
09/02/2010WO2010097469A1 Novel dioxo-imidazolidine derivatives, which inhibit the enzyme soat-1, and pharmaceutical and cosmetic compositions containing them
09/02/2010WO2010097381A1 Uses of nk receptor antagonists
09/02/2010WO2010097243A2 Process for forming solid oral dosage forms of solifenacin and its pharmaceutically acceptable salts
09/02/2010WO2010097188A1 Inhalation particles comprising a salt of carmoterol and a corticosteroid
09/02/2010WO2010097115A1 Pharmaceutical formulations comprising 4-{(1r)-2- [(6-{2-[(2,6-dichlorobenzyl)oxy] ethoxy}hexyl)amino]-1-hydroxyethyl}-2- (hydroxymethyl)phenol
09/02/2010WO2010097091A1 Methods of administering (4ar, 1oar)-i-n-propyl-i, 2,3,4a7 s1io7 ioa-octahydrobenzo [g] quinoline-6,7-diol and related compounds across the oral mucosa, the nasal mucosa or the skin and pharmaceutical compositions thereof
09/02/2010WO2010096987A1 Use of patchouli alcohol in medicament preparation
09/02/2010WO2010096886A2 Composition of a liposomal gel containing hydrocortisone, its metabolites, precursors or mixtures thereof and the use thereof
09/02/2010WO2010096868A1 Topical foam composition
09/02/2010WO2010080339A4 Phenylephrine formulations with improved stability
09/02/2010WO2010079343A3 Formulations of viable cells for oral delivery
09/02/2010WO2010056065A9 Method for preparing microspheres and microspheres produced thereby
09/02/2010WO2010038237A3 Compositions exhibiting delayed transit through the gastrointestinal tract
09/02/2010WO2010028108A3 Stable pharmaceutical composition for optimized delivery of an hiv attachment inhibitor
09/02/2010WO2009125406A3 Nail treatment device
09/02/2010WO2009112274A3 Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
09/02/2010WO2009112273A3 Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
09/02/2010WO2009094181A8 Ph-responsive nanostructures
09/02/2010US20100222751 Transdermal Drug Delivery Patch
09/02/2010US20100222432 Synthetic Carbon Nanotubes
09/02/2010US20100222419 Method to inhibit cell growth using oligonucleotides
09/02/2010US20100222375 Pharmaceutical Composition Comprising Trospium Chloride for Once-A-Day Administration
09/02/2010US20100222314 Aqueous-based Pharmaceutical Composition
09/02/2010US20100222298 Spill resistant formulations containing clays
09/02/2010US20100222220 Compositions of particulate coformulation
09/02/2010US20100221684 Implant for subcutaneous or intradermal injection
09/02/2010US20100221445 O-desmethylvenlafaxine and bazedoxifene combination product and uses thereof
09/02/2010US20100221357 Drug delivery product and methods
09/02/2010US20100221356 Pharmaceutical composition for once a day administration of trospium chloride
09/02/2010US20100221355 Pharmaceutical composition for once-a-day oral administration of trospium chloride
09/02/2010US20100221354 Pharmaceutical composition for once-a-day oral administration of trospium chloride
09/02/2010US20100221353 Pharmaceutical Composition For Once-A-Day Administration of Trospium Chloride
09/02/2010US20100221352 Pharmaceutical composition for the once-a-day oral administration of trospium chloride
09/02/2010US20100221351 Controlled Drug Delivery Using a Thermally Responsive Nanocapsule to Augment Cryoablation
09/02/2010US20100221350 Dermatological compositions comprising vitamin d lipid vesicles
09/02/2010US20100221349 Nucleic acid constructs
09/02/2010US20100221348 Therapeutic uses of dunaliella powder
09/02/2010US20100221347 Enhancing solute transport within a tissue scaffold
09/02/2010US20100221346 Method For Transfecting Cells Using A Magnetic Field
09/02/2010US20100221345 Osteogenic biomaterial containing osteogenesis promoting substance and nanogel
09/02/2010US20100221344 Functionalized Nanoceria Composition For Ophthalmic Treatment
09/02/2010US20100221343 Compositions and methods of making brittle-matrix particles through blister pack freezing
09/02/2010US20100221342 Composition and method of treating a sore throat
09/02/2010US20100221341 Alanine-Based Peptide Hydrogels
09/02/2010US20100221340 Method and compositions for treatment or prevention of inflammatory conditions
09/02/2010US20100221339 Use of a combination of morphine and at least one opiate antagonist to treat opiate dependency and prevent non-oral opiate abuse among opiate addicts
09/02/2010US20100221338 Coated Tablets Of 6-(5-Chloro-2-Pyridyl)-5-[(4-Methyl-1-Piperazinyl)Carbonyloxy]-7-Oxo-6,7-Dihydro-5H-Pyrrolo[3,4-b]Pyrazine And Methods For Measuring Effectiveness Of Coating
09/02/2010US20100221337 Method of treating arthritis, pain or inflammation with naproxen 2(methanesulfonyl)ethyl ester and an h2 receptor antagonist
09/02/2010US20100221336 Method of treating arthritis, pain or inflammation with naproxen 2(methanesulfonyl)ethyl ester and a proton pump inhibitor
09/02/2010US20100221335 Sustained-release preparation and method for producing the same
09/02/2010US20100221334 Compositions including leukotriene antagonists and nsaids and methods of using the same
09/02/2010US20100221333 Pellets Comprising a Core With a Water-Soluble Carrier
09/02/2010US20100221332 Methodology and apparatus for oral dual delivery of homeopathic products and non-homeopathic products
09/02/2010US20100221331 Pharmaceutical compositions comprising colloidal silicon dioxide
09/02/2010US20100221330 Buoyant formulations of betaine
09/02/2010US20100221329 Formulations of guanylate cyclase c agonists and methods of use
09/02/2010US20100221328 Sustained-release formulations
09/02/2010US20100221327 Nanoparticulate azelnidipine formulations
09/02/2010US20100221326 Pharmaceutical compositions for oral use for treating patients affected by obesity
09/02/2010US20100221325 Dietary supplement for healing or regressing symptoms of gastroesophageal reflux disease, gastritis and ulcers
09/02/2010US20100221324 Ph-dependent controlled release pharmaceutical composition for non-opioids with resistance against the influence of ethanol
09/02/2010US20100221323 Crystal Entecavir Formulation And The Preparation Method Thereof
09/02/2010US20100221322 Abuse-Resistant Pharmaceutical Dosage Form
09/02/2010US20100221321 Apparatus And Methods For Delivering A Plurality Of Medicaments For Management Of Co-Morbid Diseases, Illnesses Or Conditions
09/02/2010US20100221320 Active Targeting Polymer Micelle Encapsulating Drug, and Pharmaceutical Composition
09/02/2010US20100221319 Compositions and Methods for Improved Skin Care
09/02/2010US20100221318 Nucleic acids for inhibiting hairless protein expression and methods of use thereof
09/02/2010US20100221317 Dynamin mediated diseases and associated methods and products
09/02/2010US20100221316 Encapsulated Transfer Factor Compositions and Methods of Use
09/02/2010US20100221315 Vesicular formulations containing organic acid prodrugs, process for their preparation
09/02/2010US20100221314 Microneedle Device
09/02/2010US20100221312 Wound Dressings Containing Complexes of Transition Metals and Alginate for Elastase-Sequestering
09/02/2010US20100221311 Wound Dressings Containing Complexes of Transition Metals and Alginate for Elastase-Sequestering
09/02/2010US20100221310 Medical products including modified extracellular matrix materials
1 ... 851 852 853 854 855 856 857 858 859 860 861 862 863 864 865 866 867 868 869 870 871 ... 2991